Associate Professor Daniel Thomas is a Stanford-trained physician scientist who leads the Myeloid Metabolism Laboratory in the Precision Medicine Theme of the South Australian Health and Medical Research Institute at the University of Adelaide, Australia. As a clinician, Dan is passionate about direct bench to bedside translation and leads several innovative mutation-directed precision medicine clinical trials for blood cancers in Australia. Dan has published more than 48 peer-reviewed papers and he has received 16 prizes for his research including the Albert-Baikie Medal and highly competitive funding (CSL Centenary Fellowship, Snowdome and K99-R00 NCI Pathway to Independence award.